Latest news
Argent BioPharma (ASX:RGT): Why Does Cannepil Development Pathway Matter? - Kalkine MediaKalkine Media · Thu, 06 Aug 2026 03:18:00 GMTECS Botanics (ASX:ECS): Is Production Efficiency & Channels the Main Test? - Kalkine MediaKalkine Media · Thu, 06 Aug 2026 03:17:00 GMTArgent Biopharma Limited Announces Expiry and Cessation of 181,422 Options on 31 July 2026 - Kalkine MediaKalkine Media · Mon, 03 Aug 2026 07:17:58 GMTArgent BioPharma Finalizes US$5.5 Million CannEpil® Licensing Deal with Splash Beverage Group, Eliminates Major Debt - Kalkine MediaKalkine Media · Tue, 28 Jul 2026 07:00:00 GMT